Themis Medicare Limited
Themis Medicare is principally engaged in the activities pertaining to manufacturing of pharmaceutical products, especially in Formulation and API activity.
What Themis files
- Others53
- Important11
- Board Meeting11
- Updates7
- PPTs7
- Pledging3
Themis Medicare updated investor communication channels. It changed the email ID for its Company Secretary/Compliance Officer and also updated the email for its Registrar and Share Transfer Agent (RTA).
Themis Medicare has designated key executives (Executive-Chairman, MD & CEO, CFO, Company Secretary) to determine materiality and make disclosures to stock exchanges.
Themis Medicare submitted a valuation report and compliance certificate to exchanges, addressing queries on its convertible warrant preferential allotment. This advances the process for potential capital raising.
Themis Medicare's committee hiked the preferential allotment price of Convertible Equity Warrants for Vividhmargi Investments from Rs. 100 to Rs. 102.87 per warrant. This move, affecting up to 4.6 million shares, awaits shareholder and exchange approval.
Themis Medicare's committee approved issuing 45.96 lakh convertible equity warrants to Vividhmargi Investments at ₹100 each. This preferential issue is pending shareholder approval via postal ballot.